{"id":554530,"date":"2026-04-13T02:00:00","date_gmt":"2026-04-13T00:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/incretin-mimetics-for-comorbidities-such-as-type-2-diabetes-ascvd-hf-osas\/"},"modified":"2026-04-17T16:18:09","modified_gmt":"2026-04-17T14:18:09","slug":"incretin-mimetics-for-comorbidities-such-as-type-2-diabetes-ascvd-hf-osas","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/incretin-mimetics-for-comorbidities-such-as-type-2-diabetes-ascvd-hf-osas\/","title":{"rendered":"Incretin mimetics for comorbidities such as type 2 diabetes, ASCVD, HF, OSAS"},"content":{"rendered":"\n

Lifestyle-related measures are the basic framework in the treatment of overweight and obesity. However, in order to achieve and maintain the target weight, accompanying pharmacological or surgical measures are usually required. Pharmacotherapy is now a central component of comprehensive obesity management, with the focus on incretin-based therapies. These lead to effective weight reduction and current studies also show favorable effects on various concomitant diseases that occur more frequently in obese patients. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Lifestyle-related measures are the basic framework in the treatment of overweight and obesity. However, in order to achieve and maintain the target weight, accompanying pharmacological or surgical measures are usually……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":554531,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Obesity treatment: new study data","footnotes":""},"category":[11359,11513,11384,11297,11388,11442,11455,11548],"tags":[75160,13721,14224,90491,12390,17751,17444,81088,72410,12042],"powerkit_post_featured":[],"class_list":["post-554530","post","type-post","status-publish","format-standard","has-post-thumbnail","category-cardiology","category-congress-reports","category-endocrinology-and-diabetology","category-general-internal-medicine","category-nutrition","category-pharmacology-and-toxicology","category-pneumology","category-rx-en","tag-ascvd-en","tag-comorbidities","tag-hf-en","tag-incretin-mimetics","tag-obesity","tag-osas-en","tag-semaglutide-en-2","tag-surmount-en","tag-tirzepatide","tag-type-2-diabetes","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-25 23:57:09","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":554527,"slug":"incretino-mimetiques-en-cas-de-comorbidites-telles-que-diabete-de-type-2-ascvd-hf-osas","post_title":"Incr\u00e9tino-mim\u00e9tiques en cas de comorbidit\u00e9s telles que diab\u00e8te de type 2, ASCVD, HF, OSAS","href":"https:\/\/medizinonline.com\/fr\/incretino-mimetiques-en-cas-de-comorbidites-telles-que-diabete-de-type-2-ascvd-hf-osas\/"},"it_IT":{"locale":"it_IT","id":554524,"slug":"i-mimetici-dellincretina-per-le-comorbidita-come-il-diabete-di-tipo-2-lascvd-lhf-losas","post_title":"I mimetici dell'incretina per le comorbidit\u00e0 come il diabete di tipo 2, l'ASCVD, l'HF, l'OSAS.","href":"https:\/\/medizinonline.com\/it\/i-mimetici-dellincretina-per-le-comorbidita-come-il-diabete-di-tipo-2-lascvd-lhf-losas\/"},"pt_PT":{"locale":"pt_PT","id":554485,"slug":"mimeticos-da-incretina-para-comorbilidades-como-a-diabetes-tipo-2-ascvd-hf-saos","post_title":"Mim\u00e9ticos da incretina para comorbilidades como a diabetes tipo 2, ASCVD, HF, SAOS","href":"https:\/\/medizinonline.com\/pt-pt\/mimeticos-da-incretina-para-comorbilidades-como-a-diabetes-tipo-2-ascvd-hf-saos\/"},"es_ES":{"locale":"es_ES","id":554521,"slug":"mimeticos-de-la-incretina-para-comorbilidades-como-diabetes-tipo-2-ascvd-ic-osas","post_title":"Mim\u00e9ticos de la incretina para comorbilidades como diabetes tipo 2, ASCVD, IC, OSAS","href":"https:\/\/medizinonline.com\/es\/mimeticos-de-la-incretina-para-comorbilidades-como-diabetes-tipo-2-ascvd-ic-osas\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/554530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=554530"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/554530\/revisions"}],"predecessor-version":[{"id":554532,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/554530\/revisions\/554532"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/554531"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=554530"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=554530"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=554530"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=554530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}